Coding

Part:BBa_K929201

Designed by: Potsdam Bioware 2012 iGEM   Group: iGEM12_Potsdam_Bioware   (2012-09-24)

N-terminal sortase motif linked to AAV2-VP2 with kozak and CMV

CMV_kozak_N-terminal sortase motif_AAV2-VP2
UP12 BBa K929201.png
BioBrick Nr. BBa_K929201
RFC standard RFC 10
Requirement pSB1C3
Source existing part: BBa_K404161
Submitted by [http://2012.igem.org/Team:Potsdam_Bioware Potsdam_Bioware2012]


-myc-Sortase.png






















The Biobrick Sortase motif linked to AAV2-VP2 with kozak and CMV (BBa_K929201) is an altered version of the existing Biobrick pCMV_DARPin-E01_Middle-Linker_[AAV2]-VP23 (BBa_K404161). The DARPin-E01 insertion was replaced by the sortase motif with kozak sequence and CMV promoter.


UP12 Sortase.png

To bring big proteins like EGFR on the surface of the virus, the ligation of two polypeptides in a chemoselective manner could be done. The completely expressed protein e.g. EGFR should contain the C-terminal Sortase motif to be recognized by the enzyme Sortase. N-terminal Sortase motif was fused to the N-terminus of VP2/3 gene to allow the ligation by the Sortase.

This biobrick should be co-transfected with rAAV-RC (Rep/Cap conatining plasmid) with VP2 knock-out.


CMV

CMV is an immediate-early Cytomegalovirus promoter for high-level expression in many cell-types. The successfull expression of transgene was visible after an introduction of foreign genes in cells with recombinant adenovirus vectors.


Kozak

An additional Kozak sequence upstream of the start codon was inserted to improve the expression of the desired gene.


Sortase

Sortase is an enzyme which catalyzes specific ligation of two proteins to each other. In the first step the enzym recognizes the C-terminal conserved LPxTG sortase motif and cleaves this motif between Gly and Thr. The obtained thioester intermediat reacts with an N-terminal glycine, regenerating a native amide bond.

Gram positive bacteria use the sortase to covalently ligate the proteins to the peptidoglycan layers.


Capsid

The open reading frame cap on the 3'-end of the AAV-genome encodes the three viral capsid proteins VP1, VP2, and VP3. The transcription of the mRNA is regulated by the p40 promoter. Alternative splicing results in two mRNA the one encodes VP1 and the other VP2/ VP3. Appropriation (Verwendung) of an alternate splice acceptor removes the first AUG start codon for VP1. Thereby mainly formed mRNA encodes the VP2 and VP3 capsid proteins. The first AUG codon in the transcript is the initiation codon for VP3. The translation of VP2 begins at an upstream ACG non-methionin start codon resulting in an approximately 10-fold lower translation of VP2. The stop codon of the three capsid proteins is identical. The stoichiometric ratio of the three capsid proteins VP1, VP2 and VP3 forming the icosahedral form is 1:1:10.

To modify the surface exposed proteins of the recombinant virus we fused the sortase motif to the N-terminus of VP2 cap-gene. VP2 cap-gene is not essential for viral infectivity, what makes it an ideal candidate for the insertions of sequences to retarget the particle. Therefor to reduce and to specify the AAV tropism, the primary receptor motif, heparan sulfat proteoglycan motif, was koncked-out.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 2030
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 2666
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 2589
    Illegal SapI site found at 1467


[edit]
Categories
Parameters
None